Page last updated: 2024-08-25

3-deazaneplanocin and T-Cell Lymphoma

3-deazaneplanocin has been researched along with T-Cell Lymphoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bi, C; Chng, WJ; Choo, SN; Huang, G; Koh, TL; Lin, B; Liu, SC; Ng, SB; Selvarajan, V; Shimizu, N; Tan, J; Tay, JL; Wang, S; Yan, J; Yu, Q1

Other Studies

1 other study(ies) available for 3-deazaneplanocin and T-Cell Lymphoma

ArticleYear
EZH2 overexpression in natural killer/T-cell lymphoma confers growth advantage independently of histone methyltransferase activity.
    Blood, 2013, May-30, Volume: 121, Issue:22

    Topics: Adenosine; Adolescent; Adult; Aged; Aged, 80 and over; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Enhancer of Zeste Homolog 2 Protein; Female; Gene Expression Regulation, Neoplastic; Histone Methyltransferases; Histone-Lysine N-Methyltransferase; Humans; Killer Cells, Natural; Lymphoma, T-Cell; Male; MicroRNAs; Middle Aged; Mutagenesis; Polycomb Repressive Complex 2; Promoter Regions, Genetic; Up-Regulation; Young Adult

2013